Stem Cell-Based Phase I Trial to Repair Spinal Cord Injuries Produces Encouraging Results
Researchers at University of California San Diego School of Medicine report that a first-in-human phase I clinical trial in which neural stem cells were transplanted into participants with chronic spinal cord injuries produced measurable improvement in three of four subjects, with no serious adverse effects.